Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer

Cancer causes muscle mass loss, which is associated with a poor prognosis. Chemotherapy may also reduce muscle mass. We investigated skeletal muscle mass change during palliative chemotherapy for advanced gastric cancer (AGC) and its association with treatment outcomes. We retrospectively reviewed 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Song Ee, Choi, Jin Hwa, Park, Jae Yong, Kim, Beom Jin, Kim, Jae Gyu, Kim, Jong Won, Park, Joong-Min, Chi, Kyong-Choun, Hwang, In Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573603/
https://www.ncbi.nlm.nih.gov/pubmed/33077864
http://dx.doi.org/10.1038/s41598-020-74765-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573603/
https://www.ncbi.nlm.nih.gov/pubmed/33077864
http://dx.doi.org/10.1038/s41598-020-74765-8

Ejemplares similares